Chinese Expert Consensus on the Clinical Application of Ultrasound Screening for Gastric Cancer(2025 Edition)

Gastrointestinal Ultrasound Section,Ultrasound Medicine Specialized Committee of National Health Commission Capacity Building and Continuing Education, National Major Chronic Disease Prevention and Control Innovation and Integration Pilot Project Management Committee, Gastrointestinal Ultrasound Collaborative Group,Institute of Ultrasound Medicine,Tongji University, Gastrointestinal Ultrasound Section,Ultrasound Specialized Committee,China Medical Education Association, Gastrointestinal Ultrasound Expert Committee,Chinese Ultrasound Medicine Training Project, Abdominal Specialized Committee,Chinese Association of Ultrasound in Medicine and Engineering, Ultrasound Medicine Branch of Sino-Japan Medical Science and Technology Exchange Association, Gastrointestinal Ultrasound Branch of Beijing Association of Holistic Integrative Medicine, Ultrasound Medicine Branch of China National Health Association, Chinese Anti-Cancer Association Science Popularization Committee, Ultrasound Medicine Branch of Cross-Straits Medicine Exchange Association, Engineering Research Center of Digestive Endoscopy Minimally Invasive Diagnostic and Therapeutic Technologies,Ministry of Education

Acta Academiae Medicinae Sinicae ›› 2025, Vol. 47 ›› Issue (5) : 679-701.

PDF(13163 KB)
Home Journals Acta Academiae Medicinae Sinicae
Acta Academiae Medicinae Sinicae

Abbreviation (ISO4): Acta Academiae Medicinae Sinicae      Editor in chief: Xuetao CAO

About  /  Aim & scope  /  Editorial board  /  Indexed  /  Contact  / 
PDF(13163 KB)
Acta Academiae Medicinae Sinicae ›› 2025, Vol. 47 ›› Issue (5) : 679-701. DOI: 10.3881/j.issn.1000-503X.16777
Guidelines and Consensus

Chinese Expert Consensus on the Clinical Application of Ultrasound Screening for Gastric Cancer(2025 Edition)

Author information +
History +

Abstract

The five-year survival rate of gastric cancer in China is close to that in European and American countries but far lower than that in the Republic of Korea and Japan,which have established national gastric cancer screening systems.It is of great significance to build a high-quality gastric cancer screening system adaptive to China’s national conditions.Due to the large number of people at risk of gastric cancer and uneven distribution of medical resources,it is still difficult for China to carry out a nationwide gastroscopy screening plan for gastric cancer.Gastric ultrasound,with painlessness,no radiation,and easy acceptance and popularization,could be used as one of the alternative methods for initial screening of gastric cancer.Based on two gastric ultrasound-related consensuses published in 2020,this consensus elaborates on the necessity,feasibility,and existing problems of conducting preliminary gastric cancer ultrasound screening in China by analyzing the gastric cancer screening strategies and the difficulties faced by nationwide gastric cancer screening.Furthermore,this consensus introduces the indications and contraindications of gastric ultrasound examination,requirements for the operator and the contrast agent,ultrasound standard section,essentials of scanning operations,and stomach ultrasound report and data system (Su-RADS) and proposes the relevant consensus opinions accordingly.After multiple rounds of discussions and voting by experts from multiple societies,a total of 17 consensus opinions have been formed on gastric ultrasound as a preliminary screening technique for gastric cancer,with the aim of standardizing the popularization of gastric ultrasound.In addition,the consensus calls for conducting nationwide multicenter prospective studies to improve the level of evidence and provide data support for the construction of a preliminary gastric cancer ultrasound screening system that is in line with China’s national conditions.

Key words

gastric cancer screening / gastric contrast-enhanced ultrasound / gastric filling ultrasound / contrast agent / stomach ultrasound report and data system / expert consensus

Cite this article

Download Citations
Gastrointestinal Ultrasound Section,Ultrasound Medicine Specialized Committee of National Health Commission Capacity Building and Continuing Education , National Major Chronic Disease Prevention and Control Innovation and Integration Pilot Project Management Committee , Gastrointestinal Ultrasound Collaborative Group,Institute of Ultrasound Medicine,Tongji University , et al . Chinese Expert Consensus on the Clinical Application of Ultrasound Screening for Gastric Cancer(2025 Edition)[J]. Acta Academiae Medicinae Sinicae. 2025, 47(5): 679-701 https://doi.org/10.3881/j.issn.1000-503X.16777

References

[1]
中华人民共和国国家卫生健康委员会医政医管局. 胃癌诊疗指南(2022年版)[J]. 中华消化外科杂志, 2022, 21(9):1137-1164.DOI:10.3760/cma.j.cn115610-20220726-00432.
[2]
同济大学医学院超声医学研究所胃肠超声协作组, 上海超声诊疗工程技术研究中心, 国家放射与治疗临床医学研究中心, 等. 口服造影剂胃超声检查规范操作专家共识意见(草案)(2020年,上海)[J]. 中华医学超声杂志(电子版) 2020, 17(10):933-952.DOI:10.3877/cma.j.issn.1672-6448.2020.10.003.
[3]
中国医药教育协会超声专委会胃肠超声学组. 中国胃充盈超声检查专家共识[J]. 肿瘤预防与治疗, 2020, 33(11):817-827.DOI:10.3969/j.issn.1674-0904.2020.11.001.
[4]
国家卫生健康委员会医疗应急司. 胃癌筛查与早诊早治方案(2024年版)[J]. 中华肿瘤杂志, 2024, 46(10):915-916.DOI:10.3760/cma.j.cn112152-20240705-00276.
[5]
中华医学会肿瘤学分会早诊早治学组. 胃癌早诊早治中国专家共识(2023版)[J]. 中华消化外科杂志, 2024, 23(1):23-36.DOI:10.3760/cma.j.cn115610-20231207-00239.
[6]
中国胃癌筛查与早诊早治指南制定专家组, 赫捷, 等. 中国胃癌筛查与早诊早治指南(2022,北京)[J]. 中国肿瘤, 2022, 31(7):488-527.DOI:10.11735/j.issn.1004-0242.2022.07.A002.
[7]
Zeng H, Zheng R, Sun K, et al. Cancer survival statistics in China 2019-2021:a multicenter,population-based study[J]. J Natl Cancer Cent, 2024, 4(3):203-213.DOI:10.1016/j.jncc.2024.06.005.
[8]
中国抗癌协会胃癌专业委员会, 徐惠绵, 李凯. CACA胃癌整合诊治指南(精简版)[J]. 中国肿瘤临床, 2022, 49(14):703-710.DOI:10.12354/j.issn.1000-8179.2022.20220712.
[9]
朱娟, 王少明, 陈茹, 等. 胃癌筛查现状的研究进展[J]. 中华肿瘤杂志, 2020, 42(7):603-608.DOI:10.3760/cma.j.cn112152-20191125-00759.
[10]
Hamashima C, Systematic Review Group and Guideline Development Group for Gastric Cancer Screening Guidelines. Update version of the Japanese Guidelines for Gastric Cancer Screening[J]. Jpn J Clin Oncol, 2018, 48(7):673-683.DOI:10.1093/jjco/hyy077.
[11]
Ryu JE, Choi E, Lee K, et al. Trends in the Performance of the Korean National Cancer Screening Program for Gastric Cancer from 2007 to 2016[J]. Cancer Res Treat, 2022, 54(3):842-849.DOI:10.4143/crt.2021.482.
[12]
国家消化系统疾病临床医学研究中心, 中华医学会消化内镜分会, 中华医学会健康管理学分会, 等. 中国早期胃癌筛查流程专家共识意见(草案)(2017年,上海)[J]. 中华健康管理学杂志, 2018, 12(2):8-14.DOI:10.3760/cma.j.issn.1674-0815.2018.01.003.
[13]
国家消化系疾病临床医学研究中心(上海), 国家消化道早癌防治中心联盟, 中华医学会消化病学分会幽门螺杆菌学组, 等. 中国胃黏膜癌前状态和癌前病变的处理策略专家共识(2020年)[J]. 中华消化杂志, 2020, 40(11):731-741.DOI:10.3760/cma.j.cn311367-20200915-00554.
[14]
中华医学会消化内镜学分会. 中国早期胃癌内镜诊治共识(2023,太原)[J]. 中华消化内镜杂志, 2024, 41(6):421-442.DOI:10.3760/cma.j.cn321463-20240224-00092.
[15]
中国抗癌协会胃癌专业委员会, 中国医师协会外科医师分会上消化道外科医师委员会, 中国人群健康风险管理协作组-胃癌专业组, 等. 中国人群胃癌风险管理公众指南(2023版)[J]. 中华医学杂志, 2023, 103(36):2837-2849.DOI:10.3760/cma.j.cn112137-20230608-00968.
[16]
Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average-risk adults:2018 guideline update from the American Cancer Society[J]. CA Cancer J Clin, 2018, 68(4):250-281.DOI:10.3322/caac.21457.
[17]
Li D, Morgan DR, Corral JE, et al. Gastric cancer screening in the United States:a review of current evidence,challenges,and future perspectives[J]. Am J Gastroenterol, 2025, 120(4):765-777.DOI:10.14309/ajg.0000000000003301.
[18]
师金, 梁迪, 夏长金, 等. 2018-2019年河北省城市上消化道癌筛查结果分析[J]. 中国肿瘤, 2020, 29(6):419-424.DOI:10.11735/j.issn.1004-0242.2020.06.A003.
[19]
Liang Y, Jing WY, Song J, et al. Clinical application of oral contrast-enhanced ultrasound in evaluating the preoperative T staging of gastric cancer[J]. World J Gastroenterol, 2024, 30(41):4439-4448.DOI:10.3748/wjg.v30.i41.4439.
[20]
Lv M, Hui X, Yang X, et al. Comparison of the diagnostic accuracy of enhanced-CT and double contrast-enhanced ultrasound for preoperative T-staging of gastric cancer:a meta-analysis[J]. Cancer Imaging, 2025, 25(1):48.DOI:10.1186/s40644-025-00861-5.
[21]
Zhong Y, Xiao YY, Ye JY, et al. Diagnostic efficacy of contrast-enhanced gastric ultrasonography in staging gastric cancer:a meta-analysis[J]. BMC Cancer, 2024, 24(1):422. DOI:10.1186/s12885-024-12210-z.
[22]
Zheng XZ, Zhang LJ, Wu XP, et al. Oral contrast-enhanced gastric ultrasonography in the assessment of gastric lesions:a large-scale multicenter study[J]. J Ultrasound Med, 2017, 36(1):37-47.DOI:10.7863/ultra.16.01053.
[23]
张丹妮, 沈理, 张俊, 等. 胃超声检查对胃癌诊断价值的Meta分析[J]. 中华医学超声杂志(电子版), 2021, 18(4):344-354.DOI:10.3877/cma.j.issn.1672-6448.2021.04.002.
[24]
Liu Z, Guo J, Wang S, et al. Evaluation of transabdominal ultrasound with oral cellulose-based contrast agent in the detection and surveillance of gastric ulcer[J]. Ultrasound Med Biol, 2017, 43(7):1364-1371.DOI:10.1016/j.ultrasmedbio.2017.02.008.
[25]
Liu Z, Guo J, Sun S, et al. Evaluation of transabdominal ultrasound after oral administration of an echoic cellulose-based gastric ultrasound contrast agent for demonstrating small gastric subepithelial masses[J]. Abdom Imaging, 2014, 39(2):424-431.DOI:10.1007/s00261-013-0059-8.
[26]
Liu Z, Guo J, Li Y, et al. Standardized gastric ultrasound scanning planes with normal anatomical variability[J]. Ultraschall Med, 2020, 41(3):318-322.DOI:10.1055/a-0981-5866.
[27]
Liu Z, Ren W, Guo J, et al. Preliminary opinion on assessment categories of stomach ultrasound report and data system (Su-RADS)[J]. Gastric Cancer, 2018, 21(5):879-888.DOI:10.1007/s10120-018-0798-x.
[28]
Liu Z, Guo J, Wang S, et al. Evaluation of transabdominal ultrasound after oral administration of an echoic cellulose-based gastric ultrasound contrast agent for gastric cancer[J]. BMC Cancer, 2015,15:932.DOI:10.1186/s12885-015-1943-0.
[29]
Liu Z, Guo J, Li J, et al. Gastric lesions:demonstrated by transabdominal ultrasound after oral administration of an echoic cellulose-based gastric ultrasound contrast agent[J]. Ultraschall Medizin, 2016, 37(4):405-411.DOI:10.1055/s-0034-1399719.
[30]
蔡志清, 魏秋鑫, 宋军, 等. 胃充盈状态下经腹超声对早期胃癌的诊断价值[J]. 中国中西医结合影像学杂志, 2016, 14(5):546-548.DOI:10.3969/j.issn.1672-0512.2016.05.016.
[31]
Shen L, Zhang D, Huang Y, et al. Initial screening of gastric cancer using oral contrast-enhanced trans-abdominal ultrasonography in rural asymptomatic individuals[J]. Cancer Epidemiol, 2022, 80:102236.DOI:10.1016/j.canep.2022.102236.
[32]
Guan S, Yan R, Chen X, et al. Risk stratification of gastric cancer screening in community population based on oral contrast-enhanced ultrasonography examination:a 3-year follow-up analysis report[J]. Front Oncol, 2023, 13:1218800.DOI:10.3389/fonc.2023.1218800.
[33]
任薇薇, 沈理, 孙丽萍. 胃超声临床应用研究热点与展望[J]. 肿瘤影像学, 2021, 30(5):422-427.DOI:10.19732/j.cnki.2096-6210.2021.05.017.
[34]
沈理, 章建全. 积极开展胃超声检查创新发展胃癌防治研究[J]. 中华医学超声杂志(电子版), 2020, 17(10):923-926.DOI:10.3877/cma.j.issn.1672-6448.2020.10.001.
[35]
张显迪, 沈理, 丁红. 经腹超声胃癌诊断与筛查研究进展[J]. 肿瘤影像学, 2021, 30 (1):56-60.DOI:10.19732/j.cnki.2096-6210.2021.01.009.
[36]
张华斌. 胃肠道充盈超声检查[J]. 中国医学前沿杂志(电子版), 2023, 15(7):9-13.DOI:10.12037/YXQY.2023.07-03.
[37]
袁坤山, 王如蒙, 张淑欣, 等. 口服胃肠超声助显剂的研究进展[J]. 中华医学超声杂志(电子版), 2020, 17(6):587-590.DOI:10.3877/cma.j.issn.1672-6448.2020.06.019.
[38]
张新华. 胃肠超声快速入门[M]. 北京: 中国人口出版社, 2022:13-19.
[39]
周艳芳, 耿芳径, 韩彦文, 等. 实用胃肠超声诊断学[M]. 北京: 科学技术文献出版社, 2023:45-56.
[40]
关赛楠, 周希, 菅翠玲, 等. 胃壁厚度在超声筛查胃部病变中的价值[J]. 中华医学超声杂志(电子版), 2021, 18(8):782-787.DOI:10.3877/cma.j.issn.1672-6448.2021.08.013.
[41]
Shen L, Zhou C, Liu L, et al. Application of oral contrast trans-abdominal ultrasonography for initial screening of gastric cancer in rural areas of China[J]. Dig Liver Dis, 2017, 49(8):918-923.DOI:10.1016/j.dld.2017.04.008.
PDF(13163 KB)

Accesses

Citation

Detail

Sections
Recommended

/